[1]薛鸿涛,任 敏,李长彬.非小细胞肺癌患者放疗前后血清TSGF和CRP的变化及其临床意义[J].现代检验医学杂志,2016,31(02):136-138.[doi:10.3969/j.issn.1671-7414.2016.02.041]
　XUE Hong-tao,REN Min,LI Chang-bin.Impact and Clinical Significance of Radiotherapy on Serum TSGF and CRP in Patients with Non Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):136-138.[doi:10.3969/j.issn.1671-7414.2016.02.041]
点击复制

非小细胞肺癌患者放疗前后血清TSGF和CRP的变化及其临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年02期
页码:
136-138
栏目:
检验与临床
出版日期:
2016-06-01

文章信息/Info

Title:
Impact and Clinical Significance of Radiotherapy on Serum TSGF and CRP in Patients with Non Small Cell Lung Cancer
作者:
薛鸿涛1; 任 敏2; 李长彬3
1.汉中市中医医院检验科,陕西汉中 723000; 2.勉县医院检验科,陕西汉中 724200; 3.汉中市妇幼保健所检验科,陕西汉中 723000
Author(s):
XUE Hong-tao1; REN Min2; LI Chang-bin3
1.Department of Clinical Laboratory, Hanzhong Hospital of TCM,Shaanxi Hanzhong 723000,China; 2.Department of Clinical Laboratory,Mianxian Hospital,Shaanxi Hanzhong 724200,China; 3.Department of Clinical Laboratory,Hanzhong Maternity and Child Care Hospita
关键词:
非小细胞肺癌;  肿瘤特异性生长因子;  C反应蛋白;  放疗
分类号:
R734.2; R730.43
DOI:
10.3969/j.issn.1671-7414.2016.02.041
文献标志码:
A
摘要:
目的 观察非小细胞肺癌(NSCLC)放疗前后血清肿瘤特异性生长因子(TSGF)和C反应蛋白(CRP)的变化,探讨血清TSGF和CRP是否可以用于评价放疗疗效。方法 选取124例接受放射治疗的NSCLC病例,分别检测放疗前与放疗后血清TSGF和CRP水平,以P<0.05为差异具有统计学意义。结果 放疗前NSCLC患者血清CRP(8.5±1.1 mg/L)及TSGF(110.5±12.8 U/ml)水平明显高于健康志愿者(分别为1.7±0.9 mg/L和54.7±9.4 U/ml)。血清CRP水平在放疗前后差异无统计学意义。放疗后TSGF水平(54.7±9.4 U/ml)明显低于放疗前(110.5±12.8 U/ml),差异具有统计学意义。放疗有效组患者血清TSGF水平(60.7±8.9 U/ml)明显低于无效组(73.5±10.5 U/ml),差异具有统计学意义。结论 血清TSGF和CRP水平可以用于非NSCLC放疗的疗效评价指标。
Abstract:
Objective To observe the impact of radiotherapyon serum TSGF and CRP levels in patients with non-small cell lung cancer(NSCLC)and investigate whether serum TSGF and CRP levels can evaluate the effect ofradiotherapy.Methods 124 cases of NSCLC patients were treated with radiotherapy and tested serum TSGF and CRP levels before and after radiotherapy.P<0.05 was considered statistically significant.Results Before radiotherapy,serum CRP(8.5±1.1 mg/L)and TSGF levels(110.5±12.8 U/ml)in NSCLC patients were significantly higher than that inhealthy volunteers(1.7±0.9 mg/L and 54.7±9.4 U/ml).Serum CRP levels before and after radiotherapy was not statistically significant differences.After radiotherapy,TSGF levels(54.7±9.4 U/ml)were significantly lower than beforeradiotherapy(110.5±12.8 U/ml).TSGF levels in patients with radiotherapy effective group(60.7±8.9 U/ml)were significantly lower than the ineffective group(73.5±10.5 U/ml),a statistically significant difference.Conclusion The levels of serum TSGF and CRP can evaluate the effect ofradiotherapy in patients with NSCLC.

参考文献/References:

[1] Chen Y,Peng W,Lu Y,et al.MiR-200a enhances the migrations ofA549 and SK-MES-1 cells by regulating the expression of TSPAN1[J].Journalof Biosciences,2013,38(3):523-532.
[2] Liu GL,Liu X,Lu XB,et al.miR-148b functions as a tumor suppressor innon-small cell lung cancer by targeting carcinoembryonic antigen(CEA)[J].International Journal of Clinical and Experimental Medicine,2014,7(8):1990-1999.
[3] Verdecchia A,Francisci S,Brenner H,et al.Recent cancer survival in Europe:a 2000-02 period analysis of EUROCARE-4 data[J].Lancet Oncology,2007,8(9):784-796.
[4] Lu X,Yang X,Zhang Z,et al.Meta-analysis of serum tumor markers in lung cancer[J].Chinese Journal of Lung Cancer,2010,13(12):1136-1140.
[5] 袁 云.吉非替尼在晚期非小细胞肺癌靶向治疗中的疗效观察[J].实用癌症杂志,2012,27(2):190-192. Yuan Y.Gefitinib in the treatment of patients with advanced Non-small cell lung cancer[J].The Practical Journal of Cancer,2012,27(2):190-192.
[6] Bunn PA.Worldwide overview of the current status of lung cancer diagnosis and treatment[J].Archives of Pathology & Laboratory Medicine,2012,136(12):1478-1481.
[7] 高少勇,林其昌,陈公平,等.联合检测肿瘤指标在非小细胞肺癌临床诊断中的应用[J].实用医学杂志,2012,28(23):3927-3929.
[8] 束家和,周荣耀,吴丽英,等.养正消积胶囊联合化疗治疗中晚期非小细胞肺癌35例临床观察[J].世界中医药,2013,8(4):465-468. Shu JH,Zhou RY,Wu LY,et al.Clinical observation on Yangzheng xiaoji Gapsule combined wirh chemotherapy in the treatment of advanced non-small cell lung cancer 35 cases[J].World Chinese Medicine,2013,8(4):465-468.
[9] Shimada H,Nabeya Y,Okazumi S,et al.Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma[J].J Surg Oncol,2003,83(4):248-252.
[10] 柳仲秋,范志刚,贺启华,等.食管癌患者放疗前后血清TSGF检测的临床价值[J].航空航天医学杂志,2011,22(5):537-538,541. Liu ZQ,Fan ZG,He QH,et al.Clinical value of the serum levels of TSGF in patients with esophageal carcinoma around radiotherapy[J].Aerospace Medicine,2011,22(5):537-538,541.

相似文献/References:

[1]张 蕾,任亚女,曾婷婷,等.晚期非小细胞肺癌患者血液实验指标和病理分期等因素对生存时间的影响分析[J].现代检验医学杂志,2016,31(02):83.[doi:10.3969/j.issn.1671-7414.2016.02.025]
　ZHANG Lei,REN Ya-n,ZENG Ting-ting,et al.Analysis of Prognosis Related Factors in Patients with Advanced Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):83.[doi:10.3969/j.issn.1671-7414.2016.02.025]
[2]王京伟,李 艳,童永清,等.湖北地区非小细胞肺癌EGFR 基因突变及其意义的研究[J].现代检验医学杂志,2016,31(03):7.[doi:10.3969/j.issn.1671-7414.2016.03.003]
　WANG Jing-wei,LI Yan,TONG Yong-qing,et al.Detection of Epidermal Growth Factor Receptor(EGFR) Mutations and the Significance in Patients with Non-small Cell Lung Cancer(NSCLC)of Hubei Province[J].Journal of Modern Laboratory Medicine,2016,31(02):7.[doi:10.3969/j.issn.1671-7414.2016.03.003]
[3]易甲其,范艳平,周宁加,等.血清PTX-3，CYFRA21-1和TPS在非小细胞肺癌中的变化及临床意义[J].现代检验医学杂志,2015,30(05):58.[doi:10.3969/j.issn.1671-7414.2015.05.018]
　YI Jia-qi,FAN Yan-ping,ZHOU Ning-jia,et al.Changes and Clinical Significance of Serum PTX-3， CYFRA21-1，TPS in Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2015,30(02):58.[doi:10.3969/j.issn.1671-7414.2015.05.018]
[4]钱忠萍,凌 晨,祁松楠,等.围非小细胞肺癌手术期T细胞含量变化的研究[J].现代检验医学杂志,2016,31(05):55.[doi:10.3969/j.issn.1671-7414.2016.05.014]
　QIAN Zhong-ping,LING Chen,QI Song-nan,et al.Content Variation of T Cells in Perioperative Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):55.[doi:10.3969/j.issn.1671-7414.2016.05.014]
[5]黎谢梦丹,罗 凯,吴顺芳,等.华南地区非小细胞肺癌患者肿瘤组织EGFR,ALK和ROS1基因突变分析[J].现代检验医学杂志,2017,32(05):16.[doi:10.3969/j.issn.1671-7414.2017.05.005]
　LIXIE Meng-dan,LUO Kai,WU Shun-fang,et al.Mutation Analysis of EGFR,ALK and ROS1 in Tumor Tissues of Patients with Non-Small Cell Lung Cancer in South of China[J].Journal of Modern Laboratory Medicine,2017,32(02):16.[doi:10.3969/j.issn.1671-7414.2017.05.005]
[6]颜 丽,魏莲花,齐发梅,等.血清TSGF,AFP,CEA和FER联合检测在肝脏恶性肿瘤诊断中的应用价值[J].现代检验医学杂志,2018,33(05):24.[doi:10.3969/j.issn.1671-7414.2018.05.007]
　YAN Li,WEI Lian-hua,QI Fa-mei,et al.Significance of Combined Detection of TSGF,AFP,CEA and FER in the Diagnosis of Hepatic Malignancy[J].Journal of Modern Laboratory Medicine,2018,33(02):24.[doi:10.3969/j.issn.1671-7414.2018.05.007]
[7]李小龙,白巧艳,陆婉玲.老年非小细胞肺癌患者低分割放疗对凝血功能的影响[J].现代检验医学杂志,2018,33(05):142.[doi:10.3969/j.issn.1671-7414.2018.05.039]
　LI Xiao-long,BAI Qiao-yan,LU Wan-ling.Influence of Hypofractionated High-Dose Radiotherapy on Coagulation Function in Elderly Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):142.[doi:10.3969/j.issn.1671-7414.2018.05.039]
[8]郭 华a,齐宗利a,张海祥b,等.非小细胞肺癌组织EGFR/ALK/ROS1基因联合检测的临床意义[J].现代检验医学杂志,2018,33(06):17.[doi:10.3969/j.issn.1671-7414.2018.06.005]
　GUO Huaa,QI Zong-lia,ZHANG Hai-xiangb,et al.Clinical Significance of Combined Detection of EGFR/ALK/ROS1 Genes in Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):17.[doi:10.3969/j.issn.1671-7414.2018.06.005]
[9]黄 刚,陈 霏,肇玉博,等.非小细胞肺癌患者血浆miRNA-145和miRNA-221表达与临床特征及术后复发的相关性研究[J].现代检验医学杂志,2019,34(04):40.[doi:10.3969/j.issn.1671-7414.2019.04.010]
　HUANG Gang,CHEN Fei,ZHAO Yu-bo,et al.Study on the Correlation between the Expression of MicroRNA145 and MicroRNA221 in Plasma and Clinical Characteristics and Postoperative Recurrence in Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2019,34(02):40.[doi:10.3969/j.issn.1671-7414.2019.04.010]
[10]蒋玲丽,黄中强,王雪亮,等.表皮生长因子受体（EGFR）基因突变检测质控品制备及应用[J].现代检验医学杂志,2020,35(02):145.[doi:10.3969/j.issn.1671-7414.2020.02.040]
　JIANG Ling-li,HUANG Zhong-qiang,WANG Xue-liang,et al.Development and Application of Quality Control Materials for EpidermalGrowth Factor Receptor （EGFR）Mutation Determination[J].Journal of Modern Laboratory Medicine,2020,35(02):145.[doi:10.3969/j.issn.1671-7414.2020.02.040]

更新日期/Last Update: 2016-02-20